Canada: Drug Patent Term Restoration In Canada: Certificates Of Supplementary Protection

Last Updated: October 17 2018
Article by Andrea Berenbaum

Like other patents in Canada, drug patents have a term limited to twenty years from the filing date. However, unlike other products, drugs must undergo extensive clinical testing and a regulatory approval process before they may be marketed. Because drug patents are typically filed at an early stage of development, this means the effective patent term is often significantly shorter than twenty years. Until recently, Canada was the sole G7 nation that did not provide some form of patent term restoration to address such delays. This changed on September 21, 2017 with the provisional implementation of Canada’s obligations under the Comprehensive Economic and Trade Agreement (CETA) with the European Union.

Now, certain patents relating to human and veterinary drugs qualify for up to an additional two years of protection via a Certificate of Supplementary Protection (CSP). Amendments to the Patent Act provided the legislative framework governing CSPs and the new CSP Regulations specify particulars on the numerous formal, subject-matter and timing requirements determining whether a patent is eligible. As CSPs only recently became available, it may be some time before we receive interpretation from the courts regarding these provisions. In the interim, some guidance has been provided by Health Canada, the administrator of the CSP regime. This article provides a brief overview of this new form of protection with a focus on what subject-matter is considered to be eligible and important timing considerations.

To be eligible for a CSP, the patent must be in force and have issued from an application filed on or after October 1, 1989. In addition, it must pertain to a medicinal ingredient or combination of medicinal ingredients in a drug for which a notice of compliance (marketing authorization) issued on or after September 21, 2017. If the approved drug contains one medicinal ingredient, a patent meets this requirement if it contains a claim for the medicinal ingredient (either per se or in the form of a product-by-process claim) or a use of the medicinal ingredient. If the approved drug contains more than one medicinal ingredient, this requirement is only met if the patent contains a claim for all of the medicinal ingredients (again, either per se or in the form of a product-by-process claim) or a use of all of the medicinal ingredients. Claims that are directed to formulations which include additional components such as adjuvants are not eligible for a CSP. In publically available guidance, Health Canada has indicated the claimed use does not need to match the approved use. It considers any use in humans or animals, as the case may be, to be acceptable.

There may only be one CSP issued for a medicinal ingredient or combination of medicinal ingredients. The notice of compliance must also have been the first that has issued. It is not enough for these purposes that a medicinal ingredient differs from another by certain structural variations that are listed in the CSP Regulations. These include salts, enantiomers, polymorphs and others that would be familiar to those working in the drug patent field. Such variations will result in a finding that the medicinal ingredient is the same. Similarly, if combinations vary only with respect to the ratio between the medicinal ingredients, they will be treated as the same combination. However, if a medicinal ingredient or combination thereof in a drug is authorized for both human and veterinary use, these are treated as different.

There are strict timing requirements not only for filing the CSP application itself but also for filing the applications for marketing approval. The latter was implemented with the purpose of incentivizing the early introduction of new drugs into the Canadian market. Accordingly, for CSP applications filed after September 21, 2018 the application for marketing approval in Canada must have been made within a period of 12 months from the time the first submission was made in any one of the following countries/regions: the European Union (and any member country), the United States, Australia, Switzerland and Japan. Companies interested in potentially pursuing CSP protection for a new drug product should therefore ensure the regulatory strategy includes filing the application for marketing approval in Canada within this period.

Because there can only be one CSP per drug product, is it unlikely there will ever be a deluge of new CSPs in Canada. However, twenty-three applications for human use and one for veterinary use are presently listed on the CSP register maintained by Health Canada. Of the applications, fourteen have issued, only three have been refused and the remainder are still pending. All but one of the CSPs which have issued to date are for the maximum term of two years. The protection afforded by a CSP during this period is narrower in scope than the corresponding patent in that it pertains only to the making, constructing, using and selling of any drug that contains the medicinal ingredient or combination thereof and does not encompass exports. However, it is similar in that an action for infringement of a CSP may be brought and a CSP can also be added to the Patent Register.

The maximum term of two years is still shorter than other jurisdictions that provide for up to five years of patent term restoration. However, the new CSP regime is a step towards better alignment with other members of the G7 in addressing the reduced effective patent term for drug products.

A version of this article was first published in The Lawyer's Daily, © 2018 LexisNexis Canada.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on

Click to Login as an existing user or Register so you can print this article.

Similar Articles
Relevancy Powered by MondaqAI
Borden Ladner Gervais LLP
In association with
Related Topics
Similar Articles
Relevancy Powered by MondaqAI
Borden Ladner Gervais LLP
Related Articles
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Mondaq Free Registration
Gain access to Mondaq global archive of over 375,000 articles covering 200 countries with a personalised News Alert and automatic login on this device.
Mondaq News Alert (some suggested topics and region)
Select Topics
Registration (please scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of

To Use you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.


The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.


Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions